Haemonetics(HAE) - 2026 Q1 - Quarterly Results

Investor Contacts Media Contact Olga Guyette, Vice President-Investor Relations & Treasury Josh Gitelson, Sr. Director-Communications (781) 356-9763 (781) 356-9776 olga.guyette@haemonetics.com josh.gitelson@haemonetics.com David Trenk, Manager-Investor Relations (203) 733-4987 david.trenk@haemonetics.com | | | 1st Quarter | 2026 | | | --- | --- | --- | --- | --- | | n Revenue, decrease | | $321 million, | (4)% | | | (1) n Organic revenue | increase | 0.5% | | | | (2) n Organic ex-CSL increase | revenue | 12 ...